These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27837968)

  • 21. Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel.
    Ekama SO; Ilomuanya MO; Azubuike CP; Ayorinde JB; Ezechi OC; Igwilo CI; Salako BL
    Gels; 2021 Dec; 8(1):. PubMed ID: 35049550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow.
    Lai BE; Xie YQ; Lavine ML; Szeri AJ; Owen DH; Katz DF
    J Pharm Sci; 2008 Feb; 97(2):1030-8. PubMed ID: 17724667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy.
    Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD
    J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.
    Grammen C; Augustijns P; Brouwers J
    Antiviral Res; 2012 Nov; 96(2):226-33. PubMed ID: 23000496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solvent exchange-induced in situ forming gel comprising ethyl cellulose-antimicrobial drugs.
    Phaechamud T; Mahadlek J
    Int J Pharm; 2015 Oct; 494(1):381-92. PubMed ID: 26302862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.
    Herold BC; Chen BA; Salata RA; Marzinke MA; Kelly CW; Dezzutti CS; McGowan I; Galaska B; Levy L; Piper JM; Hillier S; Hendrix CW
    Clin Infect Dis; 2016 Feb; 62(3):375-382. PubMed ID: 26508513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV.
    Khan AB; Thakur RS
    Drug Dev Ind Pharm; 2018 Mar; 44(3):472-483. PubMed ID: 29082767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective diffusion coefficients for methanol in sulfuric acid solutions measured by Raman spectroscopy.
    Van Loon LL; Allen HC; Wyslouzil BE
    J Phys Chem A; 2008 Oct; 112(43):10758-63. PubMed ID: 18837493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compartmental transport model of microbicide delivery by an intravaginal ring.
    Geonnotti AR; Katz DF
    J Pharm Sci; 2010 Aug; 99(8):3514-21. PubMed ID: 20222027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracking Molecular Diffusion across Biomaterials' Interfaces Using Stimulated Raman Scattering.
    Cui H; Glidle A; Cooper JM
    ACS Appl Mater Interfaces; 2022 Jul; 14(28):31586-31593. PubMed ID: 35801584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Note on the formulation of thermosensitive and mucoadhesive vaginal hydrogels containing the miniCD4 M48U1 as anti-HIV-1 microbicide.
    Bouchemal K; Frelichowska J; Martin L; Lievin-Le Moal V; Le Grand R; Dereuddre-Bosquet N; Djabourov M; Aka-Any-Grah A; Koffi A; Ponchel G
    Int J Pharm; 2013 Oct; 454(2):649-52. PubMed ID: 23500765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases.
    A-sasutjarit R; Sirivat A; Vayumhasuwan P
    Pharm Res; 2005 Dec; 22(12):2134-40. PubMed ID: 16215775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maraviroc.
    Ball C; Chou SF; Jiang Y; Woodrow KA
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():117-24. PubMed ID: 27040202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model-based measurements of diffusion of sulfuric acid into water using Raman spectroscopy.
    Sobron P; Sobron F; Eide UM; Nielsen CJ; Rull F
    Appl Spectrosc; 2009 Dec; 63(12):1382-8. PubMed ID: 20030984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.
    Mansoor LE; Abdool Karim Q; Mngadi KT; Dlamini S; Montague C; Nkomonde N; Mvandaba N; Baxter C; Gengiah TN; Samsunder N; Dawood H; Grobler A; Frohlich JA; Abdool Karim SS
    Trials; 2014 Dec; 15():496. PubMed ID: 25527071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
    Sohrabi S; Haeri A; Mahboubi A; Mortazavi A; Dadashzadeh S
    Int J Biol Macromol; 2016 Apr; 85():625-33. PubMed ID: 26794314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
    Dobard CW; Taylor A; Sharma S; Anderson PL; Bushman LR; Chuong D; Pau CP; Hanson D; Wang L; Garcia-Lerma JG; McGowan I; Rohan L; Heneine W
    J Infect Dis; 2015 Dec; 212(12):1988-95. PubMed ID: 26071566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir Containing Thiolated Chitosan Core/Shell Nanofibers: In Vitro and in Vivo Evaluations.
    Meng J; Agrahari V; Ezoulin MJ; Zhang C; Purohit SS; Molteni A; Dim D; Oyler NA; Youan BC
    Mol Pharm; 2016 Dec; 13(12):4129-4140. PubMed ID: 27700124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides.
    das Neves J; Sarmento B
    Acta Biomater; 2015 May; 18():77-87. PubMed ID: 25700657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.